background logo image

Episode 252

Aggressive LDL Lowering: Who Benefits?

Listen, Watch & Subscribe on:

Watch

Aggressive LDL Lowering: Who Benefits?

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Bret Scher, MD

Medical Director

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Key Highlights

  • The VESALIUS-CV trial studied patients in their 50s and 60s with severe multi-vessel vascular disease who received a PCSK9 inhibitor on top of maximum statin therapy, driving LDL below 30, and found a genuine reduction in all-cause mortality over five years, with a number needed to treat of 166.
  • The STAREE trial studied healthier adults around 75 years old without known cardiovascular disease, using high-dose statins versus placebo over six years, and while major cardiac events dropped, there was no difference in overall mortality, hospitalizations, or disability-free survival.
  • Dr. Scher notes that in the STAREE population, 80 percent of deaths came from cancer, frailty, and neurocognitive decline, explaining why lowering LDL, a cardiovascular-focused intervention, failed to meaningfully impact the risks that actually mattered most to that age group.
  • He cautions that medicine often reflexively broadens treatment guidelines whenever a trial shows even modest cardiac event reduction, but argues this instinct is misapplied to older, lower-risk patients who may face side effects and polypharmacy without meaningful benefit to mortality or independence.
  • The key takeaway is that the presence of vascular disease, not age or an isolated LDL number, should drive how aggressively LDL is treated, meaning a senior starting a ketogenic diet whose LDL rises may need a very different conversation than someone with existing cardiovascular disease.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

How to Read Your Lipid Panel: Without Panicking Over One Number
Stories

How to Read Your Lipid Panel: Without Panicking Over One Number

You open your latest lab results and see your LDL highlighted in red. Your stomach drops. You haven’t even met with your doctor yet to go over the…

Read more

Lipidologist Questions the New Keto and Liver Disease Study
Podcast

Lipidologist Questions the New Keto and Liver Disease Study

In this Metabolic Mind Bitesize episode, Dr. Bret Scher tackles a new study claiming ketogenic diets worsen fatty liver disease, a finding that appears to contradict prior research showing keto helps treat fatty liver. He breaks down why this retrospective cross-sectional study from China is deeply flawed, from never verifying ketosis to ignoring reverse causality and baseline differences, then contrasts it with a much stronger body of randomized controlled trial evidence showing the opposite conclusion.

Learn more

Early Heart Disease Detection? Why You May Consider a CIMT Test
Videos

Early Heart Disease Detection? Why You May Consider a CIMT Test

Why should we rely on a blood test to assess heart disease risk when we can see the disease itself? Transcript: Introduction to Carotid Intima-Media Thickness test (CIMT).Have…

Learn more

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More
Podcast

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More

Dr. Bret Scher and producer Erica tackle listener questions in this Metabolic Mailbag episode, covering whether keto helps or hurts AFib risk, concerns over the controversial KETO-CTA study's flawed initial data, and practical troubleshooting for someone experiencing low energy and brain fog despite strict adherence to keto. They wrap up with a stepwise approach for safely raising ketone levels when standard adjustments aren't working.

Learn more

How to Read Your Lipid Panel: Without Panicking Over One Number
Stories

How to Read Your Lipid Panel: Without Panicking Over One Number

You open your latest lab results and see your LDL highlighted in red. Your stomach drops. You haven’t even met with your doctor yet to go over the…

Read more

Lipidologist Questions the New Keto and Liver Disease Study
Podcast

Lipidologist Questions the New Keto and Liver Disease Study

In this Metabolic Mind Bitesize episode, Dr. Bret Scher tackles a new study claiming ketogenic diets worsen fatty liver disease, a finding that appears to contradict prior research showing keto helps treat fatty liver. He breaks down why this retrospective cross-sectional study from China is deeply flawed, from never verifying ketosis to ignoring reverse causality and baseline differences, then contrasts it with a much stronger body of randomized controlled trial evidence showing the opposite conclusion.

Learn more

Early Heart Disease Detection? Why You May Consider a CIMT Test
Videos

Early Heart Disease Detection? Why You May Consider a CIMT Test

Why should we rely on a blood test to assess heart disease risk when we can see the disease itself? Transcript: Introduction to Carotid Intima-Media Thickness test (CIMT).Have…

Learn more

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More
Podcast

Q&A: Keto for AFib, Heart Risk, Ketone Levels & More

Dr. Bret Scher and producer Erica tackle listener questions in this Metabolic Mailbag episode, covering whether keto helps or hurts AFib risk, concerns over the controversial KETO-CTA study's flawed initial data, and practical troubleshooting for someone experiencing low energy and brain fog despite strict adherence to keto. They wrap up with a stepwise approach for safely raising ketone levels when standard adjustments aren't working.

Learn more